@article{c1b4fcbdb3754877903734f5846c5999,
title = "Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant",
keywords = "Adolescent, Adult, Antineoplastic Agents, Immunological/therapeutic use, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Inotuzumab Ozogamicin/therapeutic use, Lymphocyte Transfusion/methods, Male, Middle Aged, Neoplasm Recurrence, Local/pathology, Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology, Prognosis, Retrospective Studies, Salvage Therapy, Stem Cell Transplantation/methods, Survival Rate, Young Adult",
author = "Cristina Papayannidis and Chiara Sartor and Alida Dominietto and Elisabetta Zappone and Mario Arpinati and Giovanni Marconi and Gianluca Cristiano and Jacopo Nanni and Sarah Parisi and Francesco Barbato and Stefania Paolini and Simona Soverini and Carolina Terragna and Valentina Robustelli and Nicoletta Testoni and Gabriella Chirumbolo and Antonio Curti and Michele Cavo and Francesca Bonifazi",
year = "2021",
month = oct,
doi = "10.1002/hon.2886",
language = "English",
volume = "39",
pages = "580--583",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",
number = "4",
}